Correlation Between GlaxoSmithKline PLC and DDC Enterprise

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and DDC Enterprise at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and DDC Enterprise into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and DDC Enterprise Limited, you can compare the effects of market volatilities on GlaxoSmithKline PLC and DDC Enterprise and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of DDC Enterprise. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and DDC Enterprise.

Diversification Opportunities for GlaxoSmithKline PLC and DDC Enterprise

0.83
  Correlation Coefficient

Very poor diversification

The 3 months correlation between GlaxoSmithKline and DDC is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and DDC Enterprise Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DDC Enterprise and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with DDC Enterprise. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DDC Enterprise has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and DDC Enterprise go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and DDC Enterprise

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to generate 0.16 times more return on investment than DDC Enterprise. However, GlaxoSmithKline PLC ADR is 6.16 times less risky than DDC Enterprise. It trades about -0.33 of its potential returns per unit of risk. DDC Enterprise Limited is currently generating about -0.16 per unit of risk. If you would invest  3,745  in GlaxoSmithKline PLC ADR on August 27, 2024 and sell it today you would lose (349.00) from holding GlaxoSmithKline PLC ADR or give up 9.32% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  DDC Enterprise Limited

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
DDC Enterprise 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days DDC Enterprise Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

GlaxoSmithKline PLC and DDC Enterprise Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and DDC Enterprise

The main advantage of trading using opposite GlaxoSmithKline PLC and DDC Enterprise positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, DDC Enterprise can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DDC Enterprise will offset losses from the drop in DDC Enterprise's long position.
The idea behind GlaxoSmithKline PLC ADR and DDC Enterprise Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Stocks Directory
Find actively traded stocks across global markets